Tabi 50mg 30 Tablets

Babies: Not applicable Lactating mothers: Information is not available on the use of this medication in lactating mothers. Seek your doctor's advice. Pregnancy: It is unsafe to use in pregnancy.
Animal studies have shown that there is a risk to the developing baby. Driving: It is safe to use this medication while driving. Alcohol: Studies are not available on the use of this medication while consuming alcohol.
Seek your doctor's advice before using this medication. Kidney: It is safe to use this medication in kidney disease patients. Dose adjustment is not necessary.
Liver: Use this medication with caution in liver disease patients. Dose adjustment is necessary.
Seek your doctor's advice. Your doctor may advise liver function tests while using this medication..

Low number of red blood cells Rash Abdominal pain Breast enlargement in male Breast tenderness Constipation Appetite loss Decreased libido Depression Drowsiness Indigestion Flatulence Hot flashes Increased liver enzymes Nausea Fatigue Weight gain.

Tabi works by blocking the effect of male hormones on androgen receptors. Thus it stops the growth and spread of cancer.
Prostate cancer is a condition where there is an abnormal growth of gland cells..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• This medication is prescribed to treat prostate cancer and related conditions • Take this tablet with or without food but at a fixed. It helps to maintain constant levels of the drug in the body • Do not expose to direct sunlight because this drug makes you sensitive to the light • Your doctor may advise regular monitoring of your blood sugar, liver function tests • Tell your doctor if you observe yellow discolouration of your eyes, skin, dark urine, or stomach pain • Do not discontinue this medication until your doctor advises .

Major • Acenocoumarol + Tabi: Concurrent use of these medications may result in an increased risk of bleeding • Domperidone + Tabi: Concurrent use of these medications may result in an increased risk of qt prolongation • Phenprocoumon + Tabi: Concurrent use of these medications may result in an increased risk of bleeding • Warfarin + Tabi: Concurrent use of these medications may result in an increased risk of bleeding Moderate • Carbamazepine + Tabi: Concurrent use of these medications may result in an increased risk of carbamazepine exposure • Lomitapide + Tabi: Concurrent use of these medications may result in an increased risk of lomitapide exposure.